FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013176883> ?p ?o ?g. }

• W2013176883 endingPage "111" @default.
• W2013176883 startingPage "106" @default.
• W2013176883 abstract "Rituximab targets normal B cells and tumor B cells. We used a unique data-mining tool to identify patients with lymphoma who were treated with rituximab and who had serial pre and post rituximab immunoglobulin concentrations evaluated. After treatment, 39% (69/179) of patients had low levels of immunoglobulin G. Recurrent sinopulmonary infections were seen in 6.6% (14/211). Intravenous immune globulin appeared to reduce the frequency of infection.Rituximab has altered the treatment approach to B-cell malignancies and other diseases. Reports consider that rituximab had limited impact on serum immunoglobulins. However, anecdotes suggest that rituximab can cause symptomatic hypogammaglobulinemia. This retrospective study examined the relationship among rituximab, hypogammaglobulinemia, and treatment of symptomatic hypogammaglobulinemia with intravenous immune globulin (IVIG).Patients with serial quantitative serum immunoglobulin (SIgG) concentrations before and subsequent to rituximab administration at Memorial Sloan-Kettering Cancer Center were identified. Information regarding rituximab administration, SIgG concentrations, frequency of infection, and administration of IVIG were recorded.Between December 1998 and April 2009, 211 patients with B-cell lymphoma treated with rituximab and with serial SIgG concentrations were identified. One hundred seventy-nine (85%) patients had normal SIgG before rituximab, 32 (15%) had low SIgG. After rituximab use, hypogammaglobulinemia was identified in 38.54% of patients with initially normal SIgG. The risk was greater in patients who received maintenance rituximab. Symptomatic hypogammaglobulinemia that prompted IVIG administration developed in 6.6% of patients.In this data set, rituximab administration was associated with a high frequency of hypogammaglobulinemia, particularly symptomatic hypogammaglobulinemia, among patients who received multiple courses of rituximab. Baseline and periodic monitoring of SIgGs is appropriate in patients who receive rituximab." @default.
• W2013176883 created "2016-06-24" @default.
• W2013176883 creator A5061964017 @default.
• W2013176883 creator A5063886509 @default.
• W2013176883 creator A5064738578 @default.
• W2013176883 date "2013-04-01" @default.
• W2013176883 modified "2023-09-30" @default.
• W2013176883 title "Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections" @default.
• W2013176883 cites W1915689252 @default.
• W2013176883 cites W1994542857 @default.
• W2013176883 cites W2007836097 @default.
• W2013176883 cites W2013220008 @default.
• W2013176883 cites W2022999547 @default.
• W2013176883 cites W2027700596 @default.
• W2013176883 cites W2041652345 @default.
• W2013176883 cites W2043799126 @default.
• W2013176883 cites W2045299787 @default.
• W2013176883 cites W2045762096 @default.
• W2013176883 cites W2056538420 @default.
• W2013176883 cites W2058015212 @default.
• W2013176883 cites W2064701379 @default.
• W2013176883 cites W2064731149 @default.
• W2013176883 cites W206701898 @default.
• W2013176883 cites W2076657480 @default.
• W2013176883 cites W2077205545 @default.
• W2013176883 cites W2093653074 @default.
• W2013176883 cites W2104094148 @default.
• W2013176883 cites W2104940816 @default.
• W2013176883 cites W2110134415 @default.
• W2013176883 cites W2113135984 @default.
• W2013176883 cites W2120703089 @default.
• W2013176883 cites W2140565922 @default.
• W2013176883 cites W2140606816 @default.
• W2013176883 cites W2140888629 @default.
• W2013176883 cites W2142983050 @default.
• W2013176883 cites W2145623024 @default.
• W2013176883 cites W2151177887 @default.
• W2013176883 cites W2153665789 @default.
• W2013176883 cites W2160305510 @default.
• W2013176883 cites W2167518119 @default.
• W2013176883 cites W2167571754 @default.
• W2013176883 cites W2336504859 @default.
• W2013176883 cites W3120446748 @default.
• W2013176883 doi "https://doi.org/10.1016/j.clml.2012.11.011" @default.
• W2013176883 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4035033" @default.
• W2013176883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23276889" @default.
• W2013176883 hasPublicationYear "2013" @default.
• W2013176883 type Work @default.
• W2013176883 sameAs 2013176883 @default.
• W2013176883 citedByCount "225" @default.
• W2013176883 countsByYear W20131768832013 @default.
• W2013176883 countsByYear W20131768832014 @default.
• W2013176883 countsByYear W20131768832015 @default.
• W2013176883 countsByYear W20131768832016 @default.
• W2013176883 countsByYear W20131768832017 @default.
• W2013176883 countsByYear W20131768832018 @default.
• W2013176883 countsByYear W20131768832019 @default.
• W2013176883 countsByYear W20131768832020 @default.
• W2013176883 countsByYear W20131768832021 @default.
• W2013176883 countsByYear W20131768832022 @default.
• W2013176883 countsByYear W20131768832023 @default.
• W2013176883 crossrefType "journal-article" @default.
• W2013176883 hasAuthorship W2013176883A5061964017 @default.
• W2013176883 hasAuthorship W2013176883A5063886509 @default.
• W2013176883 hasAuthorship W2013176883A5064738578 @default.
• W2013176883 hasBestOaLocation W20131768832 @default.
• W2013176883 hasConcept C126322002 @default.
• W2013176883 hasConcept C159654299 @default.
• W2013176883 hasConcept C203014093 @default.
• W2013176883 hasConcept C2777805810 @default.
• W2013176883 hasConcept C2779338263 @default.
• W2013176883 hasConcept C2780653079 @default.
• W2013176883 hasConcept C71924100 @default.
• W2013176883 hasConcept C90924648 @default.
• W2013176883 hasConceptScore W2013176883C126322002 @default.
• W2013176883 hasConceptScore W2013176883C159654299 @default.
• W2013176883 hasConceptScore W2013176883C203014093 @default.
• W2013176883 hasConceptScore W2013176883C2777805810 @default.
• W2013176883 hasConceptScore W2013176883C2779338263 @default.
• W2013176883 hasConceptScore W2013176883C2780653079 @default.
• W2013176883 hasConceptScore W2013176883C71924100 @default.
• W2013176883 hasConceptScore W2013176883C90924648 @default.
• W2013176883 hasIssue "2" @default.
• W2013176883 hasLocation W20131768831 @default.
• W2013176883 hasLocation W20131768832 @default.
• W2013176883 hasLocation W20131768833 @default.
• W2013176883 hasLocation W20131768834 @default.
• W2013176883 hasOpenAccess W2013176883 @default.
• W2013176883 hasPrimaryLocation W20131768831 @default.
• W2013176883 hasRelatedWork W1129554768 @default.
• W2013176883 hasRelatedWork W178308771 @default.
• W2013176883 hasRelatedWork W1915809870 @default.
• W2013176883 hasRelatedWork W1978355009 @default.
• W2013176883 hasRelatedWork W1998029904 @default.
• W2013176883 hasRelatedWork W2013176883 @default.
• W2013176883 hasRelatedWork W2803613523 @default.
• W2013176883 hasRelatedWork W2900348232 @default.
• W2013176883 hasRelatedWork W2997611592 @default.

• next